Overview
Bristol-Myers Squibb Polska operates within a global biopharmaceutical company that discovers, develops and delivers medicines for patients with serious diseases. Its research areas include oncology, hematology, neuroscience, immunology and cardiovascular disease; its portfolio includes CAMZYOS and Sotyktu, while its pipeline comprises 49 compounds in development.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-01-31. Active
45 1030 1508 0000 0005 0300 1004- 70 1030 1508 0000 0005 0300 1039
- 51 1030 1508 0000 0005 0300 1187
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
6 tenders recorded as contractor, with a total value of $43,076,570.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Aug 6, 2026 | DZP.242.281.2026 -Dostawa produktów leczniczych – Preparaty CAR-T [Axicabtagene ciloleucel, Lisocabtagene maraleucel] | $7.7M$7,663,274 | Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wrocławiu | |
| Jul 28, 2026 | Zakup i dostawa produktu leczniczego Lisocabtagene maraleucel | $6.5M$6,493,787 | Uniwersytecki Szpital Kliniczny w Poznaniu | |
| Jul 14, 2026 | Sukcesywne dostawy leków dla Narodowego Instytutu Onkologii im. Marii Skłodowskiej Curie Państwowego Instytutu Badawczego Oddziału w Gliwicach | $19.2M$19,152,853 | Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Oddział w Gliwicach |
Public sector contracts
Bristol-Myers Squibb Polska is the contractor in one public sector contract, worth PLN 12.02m.
| Public buyer | Value | |
|---|---|---|
| Dolnośląskie Centrum Onkologii, Pulmonologii I Hematologii | PLN 12,020,000 |
National Health Fund (NFZ) contracts
Bristol-Myers Squibb Polska has been an NFZ healthcare provider since 2008. In 2008 it is performing 14 contracts with a total value of USD 0.00.
| Type of care | NFZ branch | Contracts | Value in 2008 |
|---|---|---|---|
| Zaopatrzenie sprzęt ortopedyczny, środki pomocnicze i lecznicze środki techniczne | dolnośląskie | 1 | USD 0.00 |
| Zaopatrzenie sprzęt ortopedyczny, środki pomocnicze i lecznicze środki techniczne | kujawsko-pomorskie | 1 | USD 0.00 |
| Zaopatrzenie sprzęt ortopedyczny, środki pomocnicze i lecznicze środki techniczne | lubelskie | 1 | USD 0.00 |
| Zaopatrzenie sprzęt ortopedyczny, środki pomocnicze i lecznicze środki techniczne | lubuskie | 1 | USD 0.00 |
| Zaopatrzenie sprzęt ortopedyczny, środki pomocnicze i lecznicze środki techniczne | łódzkie | 1 | USD 0.00 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bristol-Myers Squibb Company | 30,000 | $4,051,863.86 | 50% |
E.r. Squibb & Sons L.l.c | 30,000 | $4,051,863.86 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bayersp. z o.o. | $624,313,880.67 | talent.bayer.com | ||
| Bausch Health Polandsp. z o.o. | $433,316,311.35 | bauschhealthpoland.pl | ||
| Komtur Polskasp. z o.o. | $424,362,396.43 | komtur.pl | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.com | ||
| Novartis Polandsp. z o.o. | $378,147,128.47 | novartis.com | ||
| MSD Polska Dystrybucjasp. z o.o. | $341,786,056.16 | msd.pl | ||
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Magnapharm Polandsp. z o.o. | $90,512,785.67 | magnapharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-02-15 | Address change (Ul. Lecha Kaczyńskiego 26, 00-609, Warszawa → Aleja Armii Ludowej 26, 00-609, Warszawa) | |
| 2018-05-25 | Address change (Al. Armii Ludowej 26, 00-609, Warszawa → Ul. Lecha Kaczyńskiego 26, 00-609, Warszawa) | |
| 2016-07-07 | PKD change (Removed: 26.60.Z, 32.50.Z, 33.13.Z, 33.14.Z, 33.20.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.78.Z, 47.99.Z, 62.09.Z, 86.21.Z, 86.22.Z, 86.90.C, 86.90.D, 88.99.Z) | |
| 2010-09-23 | PKD change (Removed: 33.10.A, 33.10.B, 51.38.B, 51.46.Z, 51.70.A, 51.70.B, 52.31.Z, 52.32.Z, 52.33.Z, 52.48.G, 52.63.Z, 72.10.Z, 72.20.Z, 72.30.Z, 72.40.Z, 72.60.Z, 74.12.Z, 74.14.A, 74.84.B, 80.42.Z, 85.12.Z, 85.14.A, 85.14.C, 85.14.D, 85.32.C; Added: 26.60.Z, 32.50.Z, 33.13.Z, 33.14.Z, 33.20.Z, 46.38.Z, 46.46.Z, 46.90.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.78.Z, 47.99.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 69.20.Z, 70.22.Z, 85.59.B, 86.21.Z, 86.22.Z, 86.90.C, 86.90.D, 88.99.Z) | |
| 2006-11-03 | Share capital change (5,000,000.00 PLN → 30,000,000.00 PLN) |
FAQ
Last updated: 2026-06-17